Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-30.48	24.17	34.77
Graham Fair Price	43.74	0.90	0.63
PEG	-72.40	0.17	-0.60
Price/Book	31.44	2.55	1.94
Price/Cash Flow	23.71	76.81	62.09
Prices/Earnings	-34.28	17.18	26.14
Price/Sales	-34.28	7.87	11.97
Price/FCF	23.71	76.81	62.09
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-24.11	0.26	0.34
Operating Margin	-15.00	0.26	0.30
ROA	100.00	0.03	0.01
ROE	0.02	0.04	100.00
ROIC	0.03	0.06	71.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	4.81	-99.32
Dividends QOQ	-0.55	0.02	-97.01
EBIT QOQ	-0.19	0.70	261.67
EPS QOQ	-0.43	1.03	138.12
FCF QOQ	-0.22	0.06	-71.53
Revenue QOQ	-0.48	1.00	109.93
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-55.47
Days Sales Outstanding (DSO)	35.24	23.86	-32.31
Inventory Turnover	11000000.00	24700000.00	124.55
Debt/Capitalization	0.11	0.10	-8.14
Quick Ratio	0.90	1.01	11.98
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.97	0.99	1.64
Cash	0.12	0.12	1.64
Capex	0.00	-0.03	-100.00
Free Cash Flow	0.03	0.03	8.00
Revenue	0.16	0.32	103.29
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.08	1.08	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.09	< 0.005	89.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating